Pixium Vision SA Company
Pixium Vision develops retinal implant systems for patients who have lost their eyesight.
Total Funding:
40955870.0
Headquarters:
Paris, Ile-de-France, France
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2020-07-15
Investors Number:
7.0
Founded Date:
2011-01-01
Industry:
Neurodegenerative disease diagnosis and treatment